The rate of death from any cause was 27.2% with digitoxin and 29.5% with placebo (HR 0.86, 95% CI 0.69-1.07). The rate of a first hospital admission for worsening heart failure was 28.1% with ...

Senior researcher Dr Ali Ahmed (University of Alabama, Birmingham) told heartwire that the differing conclusions are the result of two different methodologies used to analyze the data. He said their ...

These drugs are found in a number of plants. Digoxin is extracted from the leaves of Digitalis lanata. In addition, the dyes used in the mcg 0. Use digoxin solution to obtain the appropriate dose in ...

UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...

Findings from the current study demonstrate that over half of chronic HF patients in the DIG trial had severe and more advanced disease as evidenced by the presence of NYHA III–IV symptoms, LVEF <25%, ...

Treatment with digitoxin cut the absolute risk of all-cause mortality and hospitalization for worsening HF by 4.6% compared with placebo over a median follow-up of 36 months (HR 0.82; 95% CI 0.69-0.98 ...

A potentially life threatening label mistake caused Marlex Pharmaceuticals to recall two lots of heart failure medication Digoxin. Here’s what you need to know. What Digoxin tablets are recalled?

Digoxin is an old medication that was first derived from the foxglove plant (Digitalis lanata) in 1930. It's used to treat heart failure and atrial fibrillation and works by blocking structures in ...

New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125mg and one lot of Digoxin Tablets USP, 0.25mg to the consumer level due to Label Mix-Up ...

Credit: FDA. These products were distributed nationwide. Marlex Pharmaceuticals is recalling 1 lot of Digoxin Tablets 0.125mg and 1 lot of Digoxin Tablets 0.25mg due to a label mix-up. According to ...

Digitoxin reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and a reduced ejection fraction (HFrEF), according to ...